157 related articles for article (PubMed ID: 36372643)
1. [Acceptance of an oncologic addendum for the application of the German Standardized Medication Plan in oral anticancer drug therapy].
Barnert AK; Hofmann P; Liekweg A; Kunze A; Scheid C; Hermes-Moll K; Osburg S; Jaehde U
Z Evid Fortbild Qual Gesundhwes; 2022 Dec; 175():29-42. PubMed ID: 36372643
[TBL] [Abstract][Full Text] [Related]
2. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
3. [Standardized national medication plan : The pilot projects MetropolMediplan 2016, model region Erfurt, and PRIMA].
Dormann H; Maas R; Eickhoff C; Müller U; Schulz M; Brell D; Thürmann PA; ; ;
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2018 Sep; 61(9):1093-1102. PubMed ID: 30046864
[TBL] [Abstract][Full Text] [Related]
4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
5. Medication review in German community pharmacies - Post-hoc analysis of documented drug-related problems and subsequent interventions in the ATHINA-project.
Seidling HM; Send AFJ; Bittmann J; Renner K; Dewald B; Lange D; Bruckner T; Haefeli WE
Res Social Adm Pharm; 2017 Nov; 13(6):1127-1134. PubMed ID: 27816566
[TBL] [Abstract][Full Text] [Related]
6. A qualitative systematic review of internal and external influences on shared decision-making in all health care settings.
Truglio-Londrigan M; Slyer JT; Singleton JK; Worral P
JBI Libr Syst Rev; 2012; 10(58):4633-4646. PubMed ID: 27820528
[TBL] [Abstract][Full Text] [Related]
7. [Economic aspects in the care of patients with new oral anticancer drugs: findings from the AMBORA trial].
Dürr P; Schlichtig K; Krebs S; Schramm A; Schötz L; Fromm MF; Dörje F
Z Evid Fortbild Qual Gesundhwes; 2022 Apr; 169():84-93. PubMed ID: 35249863
[TBL] [Abstract][Full Text] [Related]
8. The federal standard medication plan in practice: An observational cross-sectional study on prevalence and quality.
Mueller MA; Opitz R; Grandt D; Lehr T
Res Social Adm Pharm; 2020 Oct; 16(10):1370-1378. PubMed ID: 32061549
[TBL] [Abstract][Full Text] [Related]
9. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
10. [Information content of medication schedules prior to the implementation of the federal standard medication plan].
Waltering I; Schwalbe O; Hempel G
Z Evid Fortbild Qual Gesundhwes; 2016 Oct; 115-116():24-32. PubMed ID: 27837957
[TBL] [Abstract][Full Text] [Related]
11. Best practices: improving patient outcomes and costs in an ACO through comprehensive medication therapy management.
Brummel A; Lustig A; Westrich K; Evans MA; Plank GS; Penso J; Dubois RW
J Manag Care Spec Pharm; 2014 Dec; 20(12):1152-8. PubMed ID: 25597053
[TBL] [Abstract][Full Text] [Related]
12. Patient adherence to oral anticancer drugs: an emerging issue in modern oncology.
Foulon V; Schöffski P; Wolter P
Acta Clin Belg; 2011; 66(2):85-96. PubMed ID: 21630604
[TBL] [Abstract][Full Text] [Related]
13. [Patients on oral anticancer drugs and coordinated pathway: CHIMORAL, feedback from care providers].
Maritaz C; Napoly L; Burnel S; Lotz JP
Bull Cancer; 2020 Dec; 107(12):1210-1220. PubMed ID: 33097210
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
15. Carer administration of as-needed subcutaneous medication for breakthrough symptoms in people dying at home: the CARiAD feasibility RCT.
Poolman M; Roberts J; Wright S; Hendry A; Goulden N; Holmes EA; Byrne A; Perkins P; Hoare Z; Nelson A; Hiscock J; Hughes D; O'Connor J; Foster B; Reymond L; Healy S; Lewis P; Wee B; Johnstone R; Roberts R; Parkinson A; Roberts S; Wilkinson C
Health Technol Assess; 2020 May; 24(25):1-150. PubMed ID: 32484432
[TBL] [Abstract][Full Text] [Related]
16. Perceived barriers to pharmacist engagement in adverse drug event prevention activities in Ghana using semi-structured interview.
Acheampong F; Anto BP
BMC Health Serv Res; 2015 Sep; 15():361. PubMed ID: 26345278
[TBL] [Abstract][Full Text] [Related]
17. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
18. The Randomized AMBORA Trial: Impact of Pharmacological/Pharmaceutical Care on Medication Safety and Patient-Reported Outcomes During Treatment With New Oral Anticancer Agents.
Dürr P; Schlichtig K; Kelz C; Deutsch B; Maas R; Eckart MJ; Wilke J; Wagner H; Wolff K; Preuß C; Brückl V; Meidenbauer N; Staerk C; Mayr A; Fietkau R; Goebell PJ; Kunath F; Beckmann MW; Mackensen A; Neurath MF; Pavel M; Dörje F; Fromm MF
J Clin Oncol; 2021 Jun; 39(18):1983-1994. PubMed ID: 33822650
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
